Question 1

Do analysts prefer ARCC or CCAP?

Accepted Answer

Ares Capital presently has a consensus price target of $20.60, suggesting a potential upside of 7.60%. Crescent Capital BDC has a consensus price target of $12.63, suggesting a potential upside of 37.14%. Given Crescent Capital BDC's higher possible upside, analysts plainly believe Crescent Capital BDC is more favorable than Ares Capital. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ares Capital 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.73 Crescent Capital BDC 0 Sell rating(s) 6 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.14

Question 2

Is ARCC or CCAP a better dividend stock?

Accepted Answer

Ares Capital pays an annual dividend of $1.92 per share and has a dividend yield of 10.0%. Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 14.8%. Ares Capital pays out 142.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out -1,511.1% of its earnings in the form of a dividend. Crescent Capital BDC has increased its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Question 3

Which has preferable valuation and earnings, ARCC or CCAP?

Accepted Answer

Ares Capital has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than Ares Capital, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ares Capital $3.05B 4.50 $1.30B $1.35 14.18 Crescent Capital BDC $167.29M 2.03 $34.51M -$0.09 N/A

Question 4

Do insiders & institutionals believe in ARCC or CCAP?

Accepted Answer

27.4% of Ares Capital shares are held by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are held by institutional investors. 0.5% of Ares Capital shares are held by company insiders. Comparatively, 1.2% of Crescent Capital BDC shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Question 5

Is ARCC or CCAP more profitable?

Accepted Answer

Ares Capital has a net margin of 30.91% compared to Crescent Capital BDC's net margin of -2.02%. Ares Capital's return on equity of 9.80% beat Crescent Capital BDC's return on equity. Company Net Margins Return on Equity Return on Assets Ares Capital 30.91% 9.80% 4.50% Crescent Capital BDC -2.02% 9.02% 3.82%

Question 6

Which has more risk and volatility, ARCC or CCAP?

Accepted Answer

Ares Capital has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.57, suggesting that its share price is 43% less volatile than the broader market.

Question 7

Does the media prefer ARCC or CCAP?

Accepted Answer

In the previous week, Ares Capital had 6 more articles in the media than Crescent Capital BDC. MarketBeat recorded 9 mentions for Ares Capital and 3 mentions for Crescent Capital BDC. Ares Capital's average media sentiment score of 0.69 beat Crescent Capital BDC's score of 0.61 indicating that Ares Capital is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ares Capital 3 Very Positive mention(s) 5 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Crescent Capital BDC 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Question 8

Do analysts recommend CCAP or CGBD?

Accepted Answer

Crescent Capital BDC currently has a consensus target price of $12.63, indicating a potential upside of 37.14%. Carlyle Secured Lending has a consensus target price of $12.25, indicating a potential upside of 13.77%. Given Crescent Capital BDC's higher possible upside, equities analysts clearly believe Crescent Capital BDC is more favorable than Carlyle Secured Lending. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Crescent Capital BDC 0 Sell rating(s) 6 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.14 Carlyle Secured Lending 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29

Question 9

Is CCAP or CGBD a better dividend stock?

Accepted Answer

Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 14.8%. Carlyle Secured Lending pays an annual dividend of $1.40 per share and has a dividend yield of 13.0%. Crescent Capital BDC pays out -1,511.1% of its earnings in the form of a dividend. Carlyle Secured Lending pays out 274.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Question 10

Which has better valuation & earnings, CCAP or CGBD?

Accepted Answer

Carlyle Secured Lending has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than Carlyle Secured Lending, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Crescent Capital BDC $167.29M 2.03 $34.51M -$0.09 N/A Carlyle Secured Lending $255.57M 2.90 $69.97M $0.51 21.11

Question 11

Do institutionals & insiders have more ownership in CCAP or CGBD?

Accepted Answer

49.5% of Crescent Capital BDC shares are owned by institutional investors. Comparatively, 24.5% of Carlyle Secured Lending shares are owned by institutional investors. 1.2% of Crescent Capital BDC shares are owned by insiders. Comparatively, 0.4% of Carlyle Secured Lending shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Question 12

Is CCAP or CGBD more profitable?

Accepted Answer

Carlyle Secured Lending has a net margin of 14.26% compared to Crescent Capital BDC's net margin of -2.02%. Crescent Capital BDC's return on equity of 9.02% beat Carlyle Secured Lending's return on equity. Company Net Margins Return on Equity Return on Assets Crescent Capital BDC -2.02% 9.02% 3.82% Carlyle Secured Lending 14.26% 8.85% 3.90%

Question 13

Which has more volatility and risk, CCAP or CGBD?

Accepted Answer

Crescent Capital BDC has a beta of 0.57, meaning that its share price is 43% less volatile than the broader market. Comparatively, Carlyle Secured Lending has a beta of 0.66, meaning that its share price is 34% less volatile than the broader market.

Question 14

Does the media refer more to CCAP or CGBD?

Accepted Answer

In the previous week, Carlyle Secured Lending had 7 more articles in the media than Crescent Capital BDC. MarketBeat recorded 10 mentions for Carlyle Secured Lending and 3 mentions for Crescent Capital BDC. Carlyle Secured Lending's average media sentiment score of 0.81 beat Crescent Capital BDC's score of 0.61 indicating that Carlyle Secured Lending is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Crescent Capital BDC 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Carlyle Secured Lending 4 Very Positive mention(s) 5 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Question 15

Do analysts rate MFIC or CCAP?

Accepted Answer

MidCap Financial Investment presently has a consensus target price of $11.11, suggesting a potential upside of 27.38%. Crescent Capital BDC has a consensus target price of $12.63, suggesting a potential upside of 37.14%. Given Crescent Capital BDC's stronger consensus rating and higher probable upside, analysts plainly believe Crescent Capital BDC is more favorable than MidCap Financial Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MidCap Financial Investment 1 Sell rating(s) 6 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.11 Crescent Capital BDC 0 Sell rating(s) 6 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.14

Question 16

Is MFIC or CCAP a better dividend stock?

Accepted Answer

MidCap Financial Investment pays an annual dividend of $1.24 per share and has a dividend yield of 14.2%. Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 14.8%. MidCap Financial Investment pays out -344.4% of its earnings in the form of a dividend. Crescent Capital BDC pays out -1,511.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Crescent Capital BDC has raised its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Question 17

Which has higher earnings & valuation, MFIC or CCAP?

Accepted Answer

MidCap Financial Investment has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than MidCap Financial Investment, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MidCap Financial Investment $320.88M 2.24 $63.17M -$0.36 N/A Crescent Capital BDC $167.29M 2.03 $34.51M -$0.09 N/A

Question 18

Do insiders & institutionals believe in MFIC or CCAP?

Accepted Answer

28.5% of MidCap Financial Investment shares are held by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are held by institutional investors. 0.9% of MidCap Financial Investment shares are held by company insiders. Comparatively, 1.2% of Crescent Capital BDC shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Question 19

Is MFIC or CCAP more profitable?

Accepted Answer

Crescent Capital BDC has a net margin of -2.02% compared to MidCap Financial Investment's net margin of -9.85%. MidCap Financial Investment's return on equity of 11.17% beat Crescent Capital BDC's return on equity. Company Net Margins Return on Equity Return on Assets MidCap Financial Investment -9.85% 11.17% 4.41% Crescent Capital BDC -2.02% 9.02% 3.82%

Question 20

Which has more risk & volatility, MFIC or CCAP?

Accepted Answer

MidCap Financial Investment has a beta of 0.62, indicating that its stock price is 38% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.57, indicating that its stock price is 43% less volatile than the broader market.

Question 21

Does the media prefer MFIC or CCAP?

Accepted Answer

In the previous week, Crescent Capital BDC had 1 more articles in the media than MidCap Financial Investment. MarketBeat recorded 3 mentions for Crescent Capital BDC and 2 mentions for MidCap Financial Investment. Crescent Capital BDC's average media sentiment score of 0.61 beat MidCap Financial Investment's score of -0.83 indicating that Crescent Capital BDC is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MidCap Financial Investment 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Negative Crescent Capital BDC 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Question 22

Do analysts recommend SLRC or CCAP?

Accepted Answer

SLR Investment currently has a consensus target price of $14.10, suggesting a potential upside of 20.93%. Crescent Capital BDC has a consensus target price of $12.63, suggesting a potential upside of 37.14%. Given Crescent Capital BDC's stronger consensus rating and higher probable upside, analysts clearly believe Crescent Capital BDC is more favorable than SLR Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SLR Investment 2 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00 Crescent Capital BDC 0 Sell rating(s) 6 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.14

Question 23

Is SLRC or CCAP a better dividend stock?

Accepted Answer

SLR Investment pays an annual dividend of $1.24 per share and has a dividend yield of 10.6%. Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 14.8%. SLR Investment pays out 91.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out -1,511.1% of its earnings in the form of a dividend. Crescent Capital BDC has raised its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Question 24

Which has stronger valuation and earnings, SLRC or CCAP?

Accepted Answer

SLR Investment has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than SLR Investment, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SLR Investment $218.54M 2.91 $92.54M $1.35 8.64 Crescent Capital BDC $167.29M 2.03 $34.51M -$0.09 N/A

Question 25

Do insiders and institutionals hold more shares of SLRC or CCAP?

Accepted Answer

35.3% of SLR Investment shares are held by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are held by institutional investors. 8.8% of SLR Investment shares are held by insiders. Comparatively, 1.2% of Crescent Capital BDC shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Question 26

Is SLRC or CCAP more profitable?

Accepted Answer

SLR Investment has a net margin of 35.20% compared to Crescent Capital BDC's net margin of -2.02%. Crescent Capital BDC's return on equity of 9.02% beat SLR Investment's return on equity. Company Net Margins Return on Equity Return on Assets SLR Investment 35.20% 7.96% 3.09% Crescent Capital BDC -2.02% 9.02% 3.82%

Question 27

Which has more risk and volatility, SLRC or CCAP?

Accepted Answer

SLR Investment has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.57, meaning that its stock price is 43% less volatile than the broader market.

Question 28

Does the media favor SLRC or CCAP?

Accepted Answer

In the previous week, SLR Investment had 5 more articles in the media than Crescent Capital BDC. MarketBeat recorded 8 mentions for SLR Investment and 3 mentions for Crescent Capital BDC. Crescent Capital BDC's average media sentiment score of 0.61 beat SLR Investment's score of 0.10 indicating that Crescent Capital BDC is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SLR Investment 1 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Crescent Capital BDC 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Question 29

Do analysts prefer CCAP or BCSF?

Accepted Answer

Crescent Capital BDC presently has a consensus target price of $12.63, suggesting a potential upside of 37.14%. Bain Capital Specialty Finance has a consensus target price of $12.60, suggesting a potential upside of 13.30%. Given Crescent Capital BDC's stronger consensus rating and higher probable upside, analysts clearly believe Crescent Capital BDC is more favorable than Bain Capital Specialty Finance. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Crescent Capital BDC 0 Sell rating(s) 6 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.14 Bain Capital Specialty Finance 1 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.75

Question 30

Is CCAP or BCSF a better dividend stock?

Accepted Answer

Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 14.8%. Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 15.1%. Crescent Capital BDC pays out -1,511.1% of its earnings in the form of a dividend. Bain Capital Specialty Finance pays out 169.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years and Bain Capital Specialty Finance has increased its dividend for 4 consecutive years. Bain Capital Specialty Finance is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Question 31

Which has preferable valuation & earnings, CCAP or BCSF?

Accepted Answer

Bain Capital Specialty Finance has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than Bain Capital Specialty Finance, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Crescent Capital BDC $167.29M 2.03 $34.51M -$0.09 N/A Bain Capital Specialty Finance $273.24M 2.64 $98.76M $0.99 11.23

Question 32

Do insiders & institutionals have more ownership in CCAP or BCSF?

Accepted Answer

49.5% of Crescent Capital BDC shares are owned by institutional investors. 1.2% of Crescent Capital BDC shares are owned by insiders. Comparatively, 0.6% of Bain Capital Specialty Finance shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Question 33

Is CCAP or BCSF more profitable?

Accepted Answer

Bain Capital Specialty Finance has a net margin of 24.22% compared to Crescent Capital BDC's net margin of -2.02%. Bain Capital Specialty Finance's return on equity of 10.40% beat Crescent Capital BDC's return on equity. Company Net Margins Return on Equity Return on Assets Crescent Capital BDC -2.02% 9.02% 3.82% Bain Capital Specialty Finance 24.22% 10.40% 4.33%

Question 34

Which has more volatility & risk, CCAP or BCSF?

Accepted Answer

Crescent Capital BDC has a beta of 0.57, indicating that its share price is 43% less volatile than the broader market. Comparatively, Bain Capital Specialty Finance has a beta of 0.6, indicating that its share price is 40% less volatile than the broader market.

Question 35

Does the media favor CCAP or BCSF?

Accepted Answer

In the previous week, Crescent Capital BDC had 2 more articles in the media than Bain Capital Specialty Finance. MarketBeat recorded 3 mentions for Crescent Capital BDC and 1 mentions for Bain Capital Specialty Finance. Crescent Capital BDC's average media sentiment score of 0.61 beat Bain Capital Specialty Finance's score of -1.04 indicating that Crescent Capital BDC is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Crescent Capital BDC 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bain Capital Specialty Finance 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Negative

Metric	Crescent Capital BDC	Capital Markets Industry	Finance Sector	NASDAQ Exchange
Market Cap	$339.24M	$5.14B	$13.38B	$13.08B
Dividend Yield	14.81%	7.55%	6.03%	15.88%
P/E Ratio	-102.29	29.79	24.65	25.80
Price / Sales	2.03	1,265.90	508.23	90.99
Price / Cash	5.35	47.77	47.45	51.29
Price / Book	0.48	3.49	2.69	6.26
Net Income	$34.51M	$417.69M	$1.32B	$360.95M
7 Day Performance	-3.80%	-0.89%	-1.22%	-1.81%
1 Month Performance	-11.48%	5.09%	0.81%	-4.03%
1 Year Performance	-35.67%	3.17%	7.84%	2.18%

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCAP Crescent Capital BDC	4.051 of 5 stars	$8.99 -2.0%	$12.63 +40.4%	-35.4%	$334.49M	$167.29M	N/A	250	News Coverage
ARCC Ares Capital	2.9879 of 5 stars	$19.36 -0.4%	$20.60 +6.4%	-4.8%	$13.90B	$3.05B	14.34	4,250
CGBD Carlyle Secured Lending	3.4805 of 5 stars	$11.47 -0.4%	$12.50 +9.0%	-13.2%	$789.25M	$255.57M	22.49	2,500	News Coverage Analyst Downgrade
MFIC MidCap Financial Investment	3.1806 of 5 stars	$9.06 flat	$11.11 +22.6%	-26.1%	$746.27M	$320.88M	N/A	N/A
SLRC SLR Investment	4.4128 of 5 stars	$11.95 -0.7%	$14.10 +18.0%	-22.8%	$651.93M	$85.42M	8.85	N/A

Crescent Capital BDC (CCAP) Competitors

CCAP vs. ARCC, CGBD, MFIC, SLRC, and BCSF

How does Crescent Capital BDC compare to Ares Capital?

Summary

How does Crescent Capital BDC compare to Carlyle Secured Lending?

Summary

How does Crescent Capital BDC compare to MidCap Financial Investment?

Summary

How does Crescent Capital BDC compare to SLR Investment?

Summary

How does Crescent Capital BDC compare to Bain Capital Specialty Finance?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCAP vs. The Competition

Crescent Capital BDC Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Crescent Capital BDC (CCAP) Competitors

CCAP vs. ARCC, CGBD, MFIC, SLRC, and BCSF

How does Crescent Capital BDC compare to Ares Capital?

Do analysts prefer ARCC or CCAP?

Which has preferable valuation and earnings, ARCC or CCAP?

Does the media prefer ARCC or CCAP?

Is ARCC or CCAP more profitable?

Is ARCC or CCAP a better dividend stock?

Which has more risk and volatility, ARCC or CCAP?

Do insiders & institutionals believe in ARCC or CCAP?

Summary

How does Crescent Capital BDC compare to Carlyle Secured Lending?

Does the media refer more to CCAP or CGBD?

Is CCAP or CGBD more profitable?

Which has better valuation & earnings, CCAP or CGBD?

Do analysts recommend CCAP or CGBD?

Do institutionals & insiders have more ownership in CCAP or CGBD?

Which has more volatility and risk, CCAP or CGBD?

Is CCAP or CGBD a better dividend stock?

Summary

How does Crescent Capital BDC compare to MidCap Financial Investment?

Does the media prefer MFIC or CCAP?

Do analysts rate MFIC or CCAP?

Is MFIC or CCAP a better dividend stock?

Which has higher earnings & valuation, MFIC or CCAP?

Is MFIC or CCAP more profitable?

Which has more risk & volatility, MFIC or CCAP?

Do insiders & institutionals believe in MFIC or CCAP?

Summary

How does Crescent Capital BDC compare to SLR Investment?

Is SLRC or CCAP more profitable?

Do analysts recommend SLRC or CCAP?

Does the media favor SLRC or CCAP?

Do insiders and institutionals hold more shares of SLRC or CCAP?

Which has more risk and volatility, SLRC or CCAP?

Is SLRC or CCAP a better dividend stock?

Which has stronger valuation and earnings, SLRC or CCAP?

Summary

How does Crescent Capital BDC compare to Bain Capital Specialty Finance?

Does the media favor CCAP or BCSF?

Which has preferable valuation & earnings, CCAP or BCSF?

Do insiders & institutionals have more ownership in CCAP or BCSF?

Do analysts prefer CCAP or BCSF?

Which has more volatility & risk, CCAP or BCSF?

Is CCAP or BCSF more profitable?

Is CCAP or BCSF a better dividend stock?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCAP vs. The Competition

Crescent Capital BDC Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools